David M. Valenzuela

8 Patents

• US120656612024

  Genetic Modification of Rats

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US120605712024

  Methods and Compositions for Modifying a Targeted Locus

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US120375962024

  Targeted Modification of Rat Genome

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US119328592024

  Nuclease-mediated DNA Assembly

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US118209972023

  Methods and Compositions for the Targeted Modification of a Genome

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US116978282023

  Methods and Compositions for Targeted Genetic Modification Using Paired Guide Rnas

  Regeneran Pharmaceuticals, Inc.

  0 cites
• US115471002023

  Method for Screening Gene Expression in Lincrna-deficient Mice or Rats

  Regeneron Pharmaceuticals, Inc.

  0 cites
• US115471012023

  Non-human Animals Having a Disruption in a C9ORF72 Locus

  Regeneron Pharmaceuticals, Inc.

  0 cites